JOHN P BRANCACCIO Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN P BRANCACCIO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN P BRANCACCIO. JOHN P BRANCACCIO is Director in Tamir Biotechnology, Inc. ($ACEL.OB) and Director in Trovagene, Inc. ($XNOM.OB) and Director in SYNERGY PHARMACEUTICALS, INC. ($SGYP) and Director in ContraVir Pharmaceuticals, Inc. ($CTRV).
Latest Insider Trading Transactions of JOHN P BRANCACCIO
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XNOM.OB, HEPA, SGYP, ACEL.OB
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 22 2021 | XNOM.OB | Cardiff Oncology, ... | BRANCACCIO JOHN P | Director | Buy | P | 10.95 | 3,000 | 32,850 | 12,260 | 9.3 K to 12.3 K (+32.40 %) |
Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 91,332 | |
Jun 19 2020 | XNOM.OB | Cardiff Oncology, ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 2.60 | 28,858 | 75,031 | 76,517 | |
May 18 2020 | XNOM.OB | Cardiff Oncology, ... | BRANCACCIO JOHN P | Director | Buy | P | 1.43 | 6,993 | 10,000 | 9,260 | 2.3 K to 9.3 K (+308.47 %) |
Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 1.63 | 60,000 | 97,800 | 61,275 | |
Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 3.24 | 970 | 3,143 | 1,275 | |
Jun 24 2019 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | A | 2.48 | 44,734 | 110,940 | 47,806 | |
Jul 06 2018 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Option Exercise | M | 0.50 | 50,023 | 25,012 | 506,173 | |
Jul 06 2018 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Payment of Exercise | F | 0.00 | 13,896 | 0 | 116,571 | 130.5 K to 116.6 K (-10.65 %) |
Jul 06 2018 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Buy | M | 0.50 | 50,023 | 25,012 | 130,467 | 80.4 K to 130.5 K (+62.18 %) |
Jul 03 2018 | CTRV | ContraVir Pharmace ... | BRANCACCIO JOHN P | Director | Option Exercise | P | 1.55 | 1,725 | 2,674 | 1,725 | |
Jul 03 2018 | CTRV | ContraVir Pharmace ... | BRANCACCIO JOHN P | Director | Option Exercise | P | 1.55 | 3 | 5 | 3 | |
Jun 19 2018 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 1.80 | 114,750 | 206,550 | 556,196 | |
Jun 11 2018 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Buy | P | 0.80 | 10,000 | 8,000 | 53,167 | 43.2 K to 53.2 K (+23.17 %) |
Apr 02 2018 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Option Exercise | M | 0.50 | 50,000 | 25,000 | 441,446 | |
Apr 02 2018 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Buy | M | 0.50 | 50,000 | 25,000 | 76,944 | 26.9 K to 76.9 K (+185.57 %) |
Jan 25 2018 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | A | 0.30 | 54,322 | 16,297 | 246,130 | |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | M | 0.00 | 16,667 | 0 | 0 | |
Jan 04 2018 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Buy | M | 0.00 | 16,667 | 0 | 43,167 | 26.5 K to 43.2 K (+62.89 %) |
Oct 05 2017 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | A | 0.72 | 38,106 | 27,436 | 191,808 | |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | M | 0.00 | 12,667 | 0 | 16,667 | |
Sep 06 2017 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Buy | M | 0.00 | 12,667 | 0 | 26,500 | 13.8 K to 26.5 K (+91.57 %) |
Jun 30 2017 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 1.40 | 14,000 | 19,600 | 481,372 | |
Jun 30 2017 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Option Exercise | D | 1.40 | 14,000 | 19,600 | 467,372 | |
Jun 30 2017 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 4.50 | 62,500 | 281,250 | 481,372 | |
May 30 2017 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Buy | P | 3.59 | 6,500 | 23,335 | 30,444 | 23.9 K to 30.4 K (+27.15 %) |
Jan 04 2017 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | A | 0.00 | 16,667 | 0 | 16,667 | |
Sep 21 2016 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Option Exercise | M | 4.28 | 1,079 | 4,618 | 418,872 | |
Sep 21 2016 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Option Exercise | M | 4.61 | 1,439 | 6,634 | 419,951 | |
Sep 21 2016 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Sell | S | 5.76 | 2,518 | 14,504 | 20,444 | 23 K to 20.4 K (-10.97 %) |
Sep 21 2016 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Buy | M | 4.28 | 1,079 | 4,618 | 22,962 | 21.9 K to 23 K (+4.93 %) |
Sep 21 2016 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Buy | M | 4.61 | 1,439 | 6,634 | 21,883 | 20.4 K to 21.9 K (+7.04 %) |
Jul 20 2016 | CTRV | ContraVir Pharmace ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 1.04 | 65,000 | 67,600 | 200,656 | |
Jun 27 2016 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 3.67 | 62,500 | 229,375 | 421,390 | |
Jan 06 2016 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | A | 5.18 | 16,000 | 82,880 | 153,702 | |
Jul 28 2015 | SGYP | SYNERGY PHARMACEUT ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 7.91 | 37,000 | 292,670 | 358,890 | |
Mar 19 2015 | XNOM.OB | Trovagene, Inc. | BRANCACCIO JOHN P | Director | Option Exercise | A | 7.18 | 16,000 | 114,880 | 137,702 | |
Feb 12 2007 | ACEL.OB | Tamir Biotechnolog ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 1.49 | 15,000 | 22,350 | 15,000 | |
Jan 04 2007 | ACEL.OB | Tamir Biotechnolog ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 1.60 | 20,000 | 32,000 | 20,000 | |
Jul 24 2006 | ACEL.OB | Tamir Biotechnolog ... | BRANCACCIO JOHN P | Director | Buy | P | 2.05 | 4,000 | 8,200 | 4,000 | 0 to 4 K |
Jan 04 2006 | ACEL.OB | Tamir Biotechnolog ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 1.89 | 20,000 | 37,800 | 20,000 | |
Jan 04 2005 | ACEL.OB | Tamir Biotechnolog ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 4.38 | 20,000 | 87,600 | 20,000 | |
Jan 16 2004 | ACEL.OB | Tamir Biotechnolog ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 3.74 | 13,750 | 51,425 | 13,750 | |
Jan 16 2004 | ACEL.OB | Tamir Biotechnolog ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 3.74 | 13,750 | 51,425 | 13,750 |
Page: 1